All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2004-002122-22 | A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for treatme... | 2009-03-19 | due-trials |
Not reported | 2006-000692-15 | A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers | 2008-03-20 | due-trials |
Not reported | 2006-001415-29 | A phase IIa uncontrolled study to evaluate hair growth in subjects with male-pattern baldness using a cell suspension of expanded autologous dermal papilla cells (ICX-TRC). | 2009-02-11 | due-trials |
Not reported | 2006-003639-59 | A phase IIa open-label dose-escalation study using ICX-RHY to enhance the aesthetic appearance of nasolabial folds | 2008-05-08 | due-trials |
Not reported | 2006-006443-30 | A phase IIa open-label study using ICX-RHY to enhance the aesthetic appearance of facial skin imperfections. | 2008-05-23 | due-trials |
Not reported | 2010-023121-38 | A prospective placebo controlled phase II study to evaluate the use of allogeneic fibroblasts for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa. | 2012-09-20 | due-trials |